[1] Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biology 2016;14(8):e1002533.
[2] Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, et al. The Microbiome and Human Biology. Annu Rev Genom Hum Genet 2017;18:65-86.
[3] Buttó LF, Haller D. Dysbiosis in intestinal inflammation: Cause or consequence. International Journal of Medical Microbiology 2016;306(5):302-9.
[4] Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. Journal of translational medicine 2017;15(1):73.
[5] Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122(1):44-54.
[6] Rosenfeld Y, Shai Y. Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: Role in bacterial resistance and prevention of sepsis. BBA - Biomembranes 2006;1758(9):1513-22.
[7] Park BS, Lee J-O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Experimental & Molecular Medicine 2013;45(12):e66.
[8] Kaur N, Chen C-C, Luther J, Kao JY. Intestinal dysbiosis in inflammatory bowel disease. 2011;2(4):211-6.
[9] Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003;52(2):237-42.
[10] Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the United States 2007;104(34):13780-5.
[11] Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. The ISME Journal 2007;1(5):403-18.
[12] Winter SE, Winter MG, Xavier MN, Thiennimitr P, Pooh V, Keestra AM, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013;339(6120):708.
[13] Winter SE, Lopez CA, Bäumler AJ. The dynamics of gut‐associated microbial communities during inflammation. EMBO reports 2013;14(4):319-27.
[14] Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, et al. Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 (TLRs and Gut Flora in Colitis). PLoS ONE 2007;2(7):e662.
[15] Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17(4):223-37.
[16] Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017;198(2):564-71.
[17] Allaire JM, Crowley SM, Law HT, Chang SY, Ko HJ, Vallance BA. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity. Trends Immunol 2018;39(9):677-96.
[18] Wikman-Larhed A, Artursson P. Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption. European Journal of Pharmaceutical Sciences 1995;3(3):171-83.
[19] Chen Y, Lin Y, Davis K, Wang Q, Rnjak-Kovacina J, Li CM, et al. Robust bioengineered 3D functional human intestinal epithelium. Sci Rep 2015;5.
[20] Pan F, Han L, Zhang Y, Yu Y, Liu J. Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies. International Journal Of Food Sciences And Nutrition 2015;66(6):680-5.
[21] Gagnon M, Zihler Berner A, Chervet N, Chassard C, Lacroix C. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion. Journal of Microbiological Methods 2013;94(3):274-9.
[22] Laparra JM, Sanz Y. Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Letters in Applied Microbiology 2009;49(6):695-701.
[23] Chen WLK, Edington C, Suter E, Yu J, Velazquez JJ, Velazquez JG, et al. Integrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk. Biotechnology and Bioengineering 2017;114(11):2648-59.
[24] Tsamandouras N, Chen W, Edington C, Stokes C, Griffith L, Cirit M. Integrated gut and liver microphysiological systems for quantitative in vitro pharmacokinetic studies. An Official Journal of the American Association of Pharmaceutical Scientists 2017;19(5):1499-512.
[25] Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology 2001;2(4):361-7.
[26] O'Connor K, Morrissette M, Strandwitz P, Ghiglieri M, Caboni M, Liu H, et al. Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model. PLoS One 2019;14(11):e0224836.
[27] Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intestinal research 2015;13(1):11-8.
[28] Larsson JM, Karlsson H, Sjovall H, Hansson GC. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 2009;19(7):756-66.
[29] Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 2008;32(2):355-64.
[30] Lynn KS, Peterson RJ, Koval M. Ruffles and spikes: Control of tight junction morphology and permeability by claudins. Biochim Biophys Acta Biomembr 2020;1862(9):183339.
[31] Rooks MG, Veiga P, Wardwell-Scott LH, Tickle T, Segata N, Michaud M, et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. The ISME Journal 2014;8(7):1403.
[32] Ohland CL, Jobin C. Microbial Activities and Intestinal Homeostasis: A Delicate Balance Between Health and Disease. Cellular and Molecular Gastroenterology and Hepatology 2015;1(1):28-40.
[33] Postler TS, Ghosh S. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. Cell Metabolism 2017;26(1):110-30.
[34] Lin T-Y, Fan C-W, Maa M-C, Leu T-H. Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation. BioMedicine 2015;5(1):1-6.
[35] Dekker J, Van Beurden-Lamers WM, Oprins A, Strous GJ. Isolation and structural analysis of rat gastric mucus glycoprotein suggests a homogeneous protein backbone. The Biochemical journal 1989;260(3):717-23.
[36] Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. PNAS 2008;105(39):15064-9.
[37] Larsson J, Karlsson H, Sjovall H, Hansson G. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology 2009;19(12):1568-9.
[38] Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochimica et biophysica acta 2006;1765(2):189-222.
[39] Cornick S, Tawiah A, Chadee K. Roles and regulation of the mucus barrier in the gut. Tissue Barriers 2015;3(1-2).
[40] Lundin E, Zhang JX, Huang CB, Reuterving CO, Hallmans G, Nygren C, et al. Oat Bran, Rye Bran, and Soybean Hull Increase Goblet Cell Volume Density in the Small Intestine of the Golden Hamster a Histochemical and Stereologic Light-Microscopic Study. Scandinavian Journal of Gastroenterology 1993;28(1):15-22.
[41] Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochemical Journal 2009;420:211-9.
[42] Kinnebrew MA, Pamer EG. Innate immune signaling in defense against intestinal microbes. Immunol Rev 2012;245:113-31.
[43] Onyiah JC, Colgan SP. Cytokine responses and epithelial function in the intestinal mucosa. Cell Mol Life Sci 2016;73(22):4203-12.
[44] Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, et al. A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci Rep 2017;7:45270.
[45] Kominsky DJ, Campbell EL, Ehrentraut SF, Wilson KE, Kelly CJ, Glover LE, et al. IFN-gamma-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J Immunol 2014;192(3):1267-76.
[46] Rossi O, Karczewski J, Stolte EH, Brummer RJ, van Nieuwenhoven MA, Meijerink M, et al. Vectorial secretion of interleukin-8 mediates autocrine signalling in intestinal epithelial cells via apically located CXCR1. BMC Res Notes 2013;6:431.
[47] Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2(4):361-7.
[48] Krueger J, Ray A, Tamm I, Sehgal PB. Expression and function of interleukin-6 in epithelial cells. J Cell Biochem 1991;45(4):327-34.
[49] Beaurepaire C, Smyth D, McKay DM. Interferon-gamma regulation of intestinal epithelial permeability. J Interferon Cytokine Res 2009;29(3):133-44.
[50] Roulis M, Armaka M, Manoloukos M, Apostolaki M, Kollias G. Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology. Proc Natl Acad Sci U S A 2011;108(13):5396-401.
[51] Resende M, Cardoso MS, Ribeiro AR, Florido M, Borges M, Castro AG, et al. Innate IFN-gamma-Producing Cells Developing in the Absence of IL-2 Receptor Common gamma-Chain. J Immunol 2017;199(4):1429-39.
[52] Egea L, McAllister CS, Lakhdari O, Minev I, Shenouda S, Kagnoff MF. GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosa. J Immunol 2013;190(4):1702-13.
[53] Hirata Y, Egea L, Dann SM, Eckmann L, Kagnoff MF. GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen. Cell Host Microbe 2010;7(2):151-63.
[54] Kim E, Lembert M, Fallata GM, Rowe JC, Martin TL, Satoskar AR, et al. Intestinal Epithelial Cells Regulate Gut Eotaxin Responses and Severity of Allergy. Front Immunol 2018;9:1692.
[55] Adar T, Shteingart S, Ben Ya'acov A, Bar-Gil Shitrit A, Goldin E. From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation. Clin Immunol 2014;153(1):199-208.
[56] Adar T, Shteingart S, Ben-Ya'acov A, Shitrit AB, Livovsky DM, Shmorak S, et al. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications. Dig Dis Sci 2016;61(7):1915-24.
[57] D'Hennezel E, Abubucker S, Murphy LO, Cullen TW. Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling. mSystems 2017;2(6): e00046-17.
[58] Kulkarni N, Pathak M, Lal G. Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance. J Leukoc Biol 2017;101(2):377-94.
[59] Bondar C, Araya RE, Guzman L, Rua EC, Chopita N, Chirdo FG. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. PLoS One 2014;9(2):e89068.
[60] Chang TT, Chen JW. Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? Cardiovasc Diabetol 2016;15(1):117.
[61] Chou SY, Ajoy R, Changou CA, Hsieh YT, Wang YK, Hoffer B. CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5. Sci Rep 2016;6:37659.
[62] Jiang Y, McGee DW. Regulation of human lymphocyte IL-4 secretion by intestinal epithelial cell-derived interleukin-7 and transforming growth factor-beta. Clin Immunol Immunopathol 1998;88(3):287-96.
[63] Buckner LR, Lewis ME, Greene SJ, Foster TP, Quayle AJ. Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells. Cytokine 2013;63(2):151-65.
[64] Perrier S, Kherratia B, Deschaumes C, Ughetto S, Kemeny JL, Baudet-Pommel M, et al. IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-beta1 and IL-4. Clin Exp Immunol 2002;127(1):53-9.
[65] Carvalho FA, Aitken JD, Gewirtz AT, Vijay-Kumar M. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunol 2011;4(1):102-11.
[66] Rogier R, Ederveen THA, Boekhorst J, Wopereis H, Scher JU, Manasson J, et al. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis. Microbiome 2017;5(1):63.
[67] Martins A, Han J, Kim SO. The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis. IUBMB Life 2010;62(8):611-7.
[68] Mannon PJ, Leon F, Fuss IJ, Walter BA, Begnami M, Quezado M, et al. Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells. Clin Exp Immunol 2009;155(3):447-56.
[69] Saba S, Soong G, Greenberg S, Prince A. Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol 2002;27(5):561-7.
[70] Mendes V, Galvao I, Vieira AT. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses. J Interferon Cytokine Res 2019;39(7):393-409.
[71] Wang Y, Kim R, Hwang SJ, Dutton J, Sims CE, Allbritton NL. Analysis of Interleukin 8 Secretion by a Stem-Cell-Derived Human-Intestinal-Epithelial-Monolayer Platform. Anal Chem 2018;90(19):11523-30.
[72] Song DH, Lee JO. Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev 2012;250(1):216-29.
[73] Walter MJ, Kajiwara N, Karanja P, Castro M, Holtzman MJ. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001;193(3):339-51.
[74] Peluso I, Pallone F, Monteleone G. Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006;12(35):5606-10.
[75] Cane G, Moal VL, Pages G, Servin AL, Hofman P, Vouret-Craviari V. Up-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coli. PLoS One 2007;2(12):e1359.
[76] Schlieve CR, Mojica SG, Holoyda KA, Hou X, Fowler KL, Grikscheit TC. Vascular Endothelial Growth Factor (VEGF) Bioavailability Regulates Angiogenesis and Intestinal Stem and Progenitor Cell Proliferation during Postnatal Small Intestinal Development. PLoS One 2016;11(3):e0151396.
[77] Levast B, Li Z, Madrenas J. The role of IL-10 in microbiome-associated immune modulation and disease tolerance. Cytokine 2015;75(2):291-301.
[78] Mishima Y, Oka A, Liu B, Herzog JW, Eun CS, Fan TJ, et al. Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells. J Clin Invest 2019;129(9):3702-16.
[79] Veremeyko T, Siddiqui S, Sotnikov I, Yung A, Ponomarev ED. IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS One 2013;8(12):e81774.
[80] Ma YL, Huang FJ, Cong L, Gong WC, Bai HM, Li J, et al. IL-4-Producing Dendritic Cells Induced during Schistosoma japonica Infection Promote Th2 Cells via IL-4-Dependent Pathway. J Immunol 2015;195(8):3769-80.
[81] Bahrami B, Macfarlane S, Macfarlane GT. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines. J Appl Microbiol 2011;110(1):353-63.
[82] Lugering N, Kucharzik T, Kraft M, Winde G, Sorg C, Stoll R, et al. Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells. Dig Dis Sci 1999;44(3):649-55.
[83] Thorn M, Raab Y, Larsson A, Gerdin B, Hallgren R. Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis. Scand J Gastroenterol 2000;35(4):408-12.
[84] Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95(1):55-65.
[85] Rettedal E, Gumpert H, Sommer MOA. Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nature Communications 2014;5.
[86] Kuczynski J, Stombaugh J, Walters WA, González A, Caporaso JG, Knight R. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Current protocols in bioinformatics 2011;Chapter 10:Unit 10.7.
[87] McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012;6(3):610-8.
[88] Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019;37(8):852-7.
[89] Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013;31(9):814-21.
[90] Hall RL, Miller RJ, Peatfield AC, Richardson PS, Williams I, Lampert I. A colorimetric assay for mucous glycoproteins using Alcian Blue proceedings. Biochemical Society transactions 1980;8(1):72.